| Literature DB >> 35918770 |
Larissa Sattler1, Luke Kisaloff2, Taiyler Cragnolini2, Radd Peters2, Wayne Hing2.
Abstract
BACKGROUND: The length of hospital stay after lower limb arthroplasty has rapidly decreased in the last decade, largely in part due to the rise of improved perioperative protocols, but also as a response to the increased economic demand associated with the rapid growth in hip and knee arthroplasty procedures. In line with this, the development of a new pathway after lower limb arthroplasty that allows for the surgery to be performed in an outpatient setting and permits for same-day discharge after the procedure is increasingly being offered. Although costs and complications between the inpatient and outpatient models have been compared, there appears to be little known about the effects on a patient's physical function after undergoing hip or knee outpatient arthroplasty. Therefore, this systematic review aims to explore the available evidence for the effect on functional outcomes following inpatient versus outpatient hip or knee arthroplasty.Entities:
Keywords: Functional outcome measures; Hip Arthroplasty; Knee Arthroplasty; Outpatient Arthroplasty; Same-day discharge
Mesh:
Year: 2022 PMID: 35918770 PMCID: PMC9344712 DOI: 10.1186/s13018-022-03270-7
Source DB: PubMed Journal: J Orthop Surg Res ISSN: 1749-799X Impact factor: 2.677
Database search strategies
| Database | Search strategy |
|---|---|
| PubMed | (("outpatient"[Title/Abstract] OR "ambulatory surg*"[Title/Abstract] OR "day of surgery"[Title/Abstract] OR "same day discharge"[Title/Abstract])) AND (("knee replacement"[Title/Abstract] OR "knee arthroplasty"[Title/Abstract] OR "hip replacement"[Title/Abstract] OR "hip arthroplasty"[Title/Abstract] OR "lower limb arthroplasty"[Title/Abstract])) |
| CINAHL | (((TI outpatient OR AB outpatient) OR (TI "ambulatory surg*" OR AB "ambulatory surg*") OR (TI "day of surgery" OR AB "day of surgery") OR (TI "same day discharge" OR AB "same day discharge"))) AND (((TI "knee replacement" OR AB "knee replacement") OR (TI "knee arthroplasty" OR AB "knee arthroplasty") OR (TI "hip replacement" OR AB "hip replacement") OR (TI "hip arthroplasty" OR AB "hip arthroplasty") OR (TI "lower limb arthroplasty" OR AB "lower limb arthroplasty"))) |
| EMBASE | ((outpatient:ti,ab OR "ambulatory surg*":ti,ab OR "day of surgery":ti,ab OR "same day discharge":ti,ab)) AND (("knee replacement":ti,ab OR "knee arthroplasty":ti,ab OR "hip replacement":ti,ab OR "hip arthroplasty":ti,ab OR "lower limb arthroplasty":ti,ab)) |
Results of functional outcome measures across three or more studies
| Author | Arthroplasty type | Timepoint | Mean (SD where reported) | Statistical significance ( | |
|---|---|---|---|---|---|
| Outpatient | Inpatient | ||||
| Gabor, 2020 | THA | 12 weeks—baseline average | − 4.8 (2.2) | − 5.1 (2.3)† | 0.05* |
| Goyal, 2016 | THA | Day of surgery | 2.8 (2.5) | 3.3 (2.3) | 0.12 |
| Day after Surgery | 3.7 (2.3) | 2.8 (2.1)† | 0.05* | ||
| 4 weeks | 1.7 (1.9) | 1.7 (1.9) | 0.77 | ||
| Husted, 2020 | THA | POD1-7 | NR | NR | > 0.05 |
| TKA rest | POD1 | 4.6 | 4.0 | 0.30 | |
| POD2 | 5.2 | 3.6† | 0.02* | ||
| POD7 | 3.6 | 3.3 | 0.70 | ||
| TKA active | POD1 | 5.4 | 5.6 | 0.70 | |
| POD7 | 4.6 | 4.7 | 0.90 | ||
| Rosinsky, 2020 | THA | 2 years | 1.0 (2.0)† | 1.5 (2.2) | 0.04* |
| Zomar, 2021 | THA | Discharge | 3.1 (0.5)† | 4.6 (0.5) | 0.04* |
| 2 weeks | 2.6 (0.5) | 2.5 (0.5) | > 0.05 | ||
| 6 weeks | 1.6 (0.5) | 1.2 (0.5) | > 0.05 | ||
| 12 weeks | 1.0 (0.4) | 0.6 (0.4) | > 0.05 | ||
| Goyal, 2016 | THA | 4 weeks | 75.0 (18) | 75.0 (14) | 0.77 |
| Rosinsky, 2020 | THA | 2 years | 92.3 (13.4)† | 87.4 (15.6) | 0.02* |
| Zomar, 2021 | THA | 12 weeks | 96.3 (1.3) | 95.8 (1.2) | > 0.05 |
| Husted, 2020 | THA/TKA | 4 weeks | 75.0 (18) | 75.0 (14) | 0.77 |
| Kolisek, 2009 | TKA | 2 years | 92.3 (13.4)† | 87.4 (15.6) | 0.02* |
| Rosinsky, 2020 | THA | 12 weeks | 96.3 (1.3) | 95.8 (1.2) | > 0.05 |
NR—not reported, HHS—Harris Hip Score, POD—postoperative day, SDD—same day discharge, nSDD—not same day discharge, SD—standard deviation, THA—total hip arthroplasty, TKA—total knee arthroplasty, VAS—Visual Analog Scale
*Statistical significance = < .05
†Result favouring group
Results of functional outcome measures across less than three studies
| Author | Time point | Outpatient | Inpatient | Statistical significance ( |
|---|---|---|---|---|
| Gauthier-Kwan, 2018 | POD 1 | 3.6 (1.5) | 3.2 (2.2) | 0.20 |
| POD 7 | 2.9 (1.9) | 3.0 (1.9) | 0.82 | |
| POD 14 | 2.9 (2.1) | 2.9 (1.9) | 0.86 | |
| POD 21 | 2.3 (1.8) | 2.4 (1.8) | 0.80 | |
| POD 28 | 2.1 (1.7) | 2.0 (1.9) | 0.60 | |
| Husted, 2020 | NR | > 0.05 | ||
| Rosinsky, 2020 | 2 years | 80.0 (22.7) | 71.2 (30.8) | 0.16 |
| Rosinsky, 2020 | 2 years | 91.5 (14.7)† | 86.2 (17.1) | 0.02* |
| Gabor, 2020 | 12 weeks—baseline Average | 29.9 (16.7) | 31.3 (16.7) | 0.29 |
| Kolisek, 2009 | 24 months | 123 | 121 | 0.28 |
| Husted, 2020 | 3 months | 32 | 31 | 0.60 |
| 1 year | 39 | 38 | 0.50 | |
| Husted, 2020 | 3 months | 39 | 37 | 0.10 |
| 1 year | 43 | 43 | 1.00 | |
| Gauthier-Kwan, 2018 | POD 1 | 15.4 (2.0)† | 13.9 (2.8) | 0.01* |
| POD 3 | 16.4 (1.8) | 15.6 (2.5) | 0.30 | |
| POD 7 | 16.4 (1.8) | 16.2 (2.1) | 0.62 | |
| POD 14 | 15.8 (2.2) | 16.4 (2.0) | 0.12 | |
| POD 21 | 16.2 (3.1) | 16.6 (2.0) | 0.59 | |
| POD 28 | 16.4 (3.0) | 16.8 (1.8) | 0.44 |
NR—not reported, POD—post operative day, SD—standard deviation
*Statistical significance = < .05
†Result favouring group
Results of outcome measures with subscales
| Author, year | Time point | Subscale | Outpatient | Inpatient | Statistical significance ( |
|---|---|---|---|---|---|
| Gauthier-Kwan, 2018 | 1 year | Symptoms | 73.1 (15.5) | 79.2 (17.3) | 0.11 |
| Pain | 82.1 (16.2) | 83.8 (18.0) | 0.59 | ||
| ADL | 86.2 (13.9) | 85.4 (17.6) | 0.81 | ||
| SR | 60.2 (25.8) | 54.7 (27.2) | 0.53 | ||
| QoL | 57.4 (25.9) | 70.9 (23.2) | 0.05 | ||
| 2 year | Symptoms | 80.2 (12.3) | 79.6 (17.6) | 0.56 | |
| ADL | 88.1 (13.4) | 88.7 (14.8) | 0.50 | ||
| Pain | 89.5 (13.2) | 88.1 (16.5) | 0.96 | ||
| SR | 61.5 (25.7) | 64.0 (23.1) | 0.77 | ||
| QoL | 69.4 (19.3) | 76.0 (24.2) | 0.09 | ||
| Gauthier-Kwan, 2018 | 1 year | Pain | 88.1 (13.0) | 87.1(17.3) | 0.78 |
| Stiffness | 75.0 (13.7) | 80.7 (18.5) | 0.13 | ||
| Function | 86.2 (13.9) | 85.5 (17.6) | 0.81 | ||
| Total | 84.6 (12.0) | 85.1 (16.8) | 0.43 | ||
| 2 year | Pain | 92.6 (12.0) | 87.7 (21.3) | 0.31 | |
| Stiffness | 82.3 (16.4) | 82.5 (20.0) | 0.65 | ||
| Function | 89.5 (13.2) | 88.2 (16.5) | 0.95 | ||
| Total | 89.3 (12.5) | 87.9 (15.9) | 0.93 | ||
| Kolisek, 2009 | 24 months | Knee Score | 94 | 93 | 0.26 |
| Function Score | 86 | 86 | 0.96 |
ADL—activities of daily living, QoL—quality of life, SR—sport and recreation, SD—standard deviation
Statistical significance = < .05
Results of Veteran Rand-12 and Short form-12
| Author, year | Time point | Outpatient | Inpatient | Statistical significance ( | Outpatient | Inpatient | Statistical significance ( |
|---|---|---|---|---|---|---|---|
| VR-12P mean (SD) | VR-12M mean (SD) | ||||||
| Rosinsky, 2020 | 2 years | 51.4 (8.9) | 48.9 (10.6) | 0.121 | 62.1 (5.5) | 60.4 (8.0) | 0.15 |
| Gabor, 2020 | 12 weeks—baseline Average | 4.3 (10.2) | 6.1 (11.1) | 0.040 | 14.1 (10.1) | 14.4 (8.8) | 0.65 |
| SF-12P mean (SD) | SF-12M mean (SD) | ||||||
| Rosinsky, 2020 | 2 years | 49.8 (9.5) | 47.4 (11.0) | 0.132 | 57.7 (5.4) | 56.3 (7.9) | 0.37 |
| Zomar, 2021 | 2 weeks | 31.5 (2.0) | 31.1 (1.8) | > 0.05 | 56.8 (2.6) | 50.9 (2.3) | > 0.05 |
| 6 weeks | 40.1 (2.7) | 42.3 (2.4) | > 0.05 | 54.5 (2.2) | 54.1 (2.0) | > 0.05 | |
| 12 weeks | 45.6 (2.5) | 45.3 (2.3) | > 0.05 | 56.9(1.8) | 55.9 (1.6) | > 0.05 | |
SD—standard deviation, VR-12—veterans rand-12, SF-12—short form-12
Results of gait analysis including timed up & go
| Author, year | Time point | Characteristic | Outpatient | Inpatient | Statistical significance |
|---|---|---|---|---|---|
| Zomar, 2021 | 12 weeks | Velocity (cm/s) | 116.8 (3.9) | 114.9 (3.4) | > 0.05 |
| Stride length (cm) | 130.5 (2.9) | 129.3 (2.6) | > 0.05 | ||
| Double limb support (% gait cycle) | 27.6 (0.7) | 28.8 (0.7) | > 0.05 | ||
| Single limb support (% of git cycle) operated limb | 36.6 (0.5) | 35.5 (0.5) | > 0.05 | ||
| Step length (cm) operated limb | 66.7 (1.3) | 65.3 (1.2) | > 0.05 | ||
| TUG (s) | 8.54 (0.47) | 9.35 (0.42) | > 0.05 |
SD—standard deviation, TUG—timed up & go
Fig. 1PRISMA flow diagram of study screening and selection
JBI critical appraisal score
| Q1 | Q2 | Q3 | Q4 | Q5 | Q6 | Q7 | Q8 | Q9 | Q10 | Q11 | Raw score/11 | (%) | Quality Rating | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JBI critical appraisal checklist for | ||||||||||||||
| Gabor, 2020 | N | Y | Y | Y | Y | Y | Y | Y | U | U | Y | 8 | 72.7 | Good |
| Gauthier-Kwan, 2018 | Y | Y | Y | Y | Y | Y | Y | Y | Y | U | Y | 10 | 90.9 | Good |
| Husted, 2020 | Y | Y | Y | Y | Y | Y | Y | Y | U | U | Y | 9 | 81.8 | Good |
| Kolisek, 2009 | N | Y | Y | Y | U | Y | Y | Y | Y | Y | U | 8 | 72.7 | Good |
| Zomar, 2020 | U | Y | Y | Y | Y | Y | Y | Y | U | U | Y | 8 | 72.7 | Good |
GMQ—good methodological quality, N—did not meet criteria, U—unclear, Y—met criteria
Study overview and participant characteristics
| Author, Year, Country | Title | Study Design | Level of Evidence* | Arthro-plasty | Participant numbers | Sex (M/F) | Age (Years) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OP | IP | |||||||||||||
| OP | IP | OP | IP | Mean | Range | SD | Mean | Range | SD | |||||
| Gabor, 2020, USA | Similar Outcomes After Hospital-Based Same-Day Discharge vs Inpatient Total Hip Arthroplasty | Retrospective Cohort | Level III-2 | THA | 415 | 548 | 202/213 | 196/352 | ≤ 59–91 | ≤ 59–91 | ||||
| Goyal, 2016, USA | A Multicentre, Randomized Study of Outpatient versus Inpatient Total Hip Arthroplasty | Randomised Control Trial | Level II | THA | 112 | 108 | 59/53 | 58/50 | 59.8 | 27–74 | ± 8.5 | 60.2 | 34–74 | ± 8.9 |
| Gauthier-Kwan, 2018, Canada | Quality of Recovery, Post-discharge Hospital Utilization, and 2-YearFunctional Outcomes After an Outpatient Total Knee Arthroplasty Program | Prospective Cohort | Level III-2 | TKA | 43 | 43 | 29/14 | 22/21 | 62.5 | 50–75 | 62.5 | 51–74 | ||
| Husted, 2020, Denmark | Are functional outcomes and early pain affected by discharge on the day of surgery following total hip and knee arthroplasty? | Prospective Cohort | Level III-2 | THA/TKA | 92 | 169 | 53/39 | 80/89 | 60 | ± 11 | 62 | ± 11 | ||
| Kolisek, 2009, USA | Comparison of Outpatient versus Inpatient Total Knee Arthroplasty | Prospective Cohort | Level III-2 | TKA | 64 | 64 | 40/24 | 40/24 | 55 | 42–64 | 55 | 42–64 | ||
| Rosinsky, 2020, USA | Outpatient vs. inpatient hip arthroplasty: a matched case–control study on a 90-day complication rate and 2-year patient-reported outcomes | Case–Control | Level III-2 | THA | 91 | 91 | 53/38 | 49/42 | 53.3 | 29–65 | ± 7.2 | 55.3 | 36–75 | ± 6.9 |
| Zomar, 2021, England | Perioperative gait analysis after total hip arthroplasty: Does outpatient surgery compromise patient outcomes? | Prospective Cohort | Level III-2 | THA | 16 | 20 | 9/7 | 12/8 | 56.8 | ± 7.9 | 64.6 | ± 9.0 | ||
ADL—activities of daily living, ASA—American Society of Anaesthesiologists Physical Status Classification system, BMI—body mass index, DOS—day of surgery, F—Female, M—Male, IP—Inpatient, OP—Outpatient, OA—osteoarthritis, SDD—same day discharge, nSDD—Not Same-day discharge, SD—Standard Deviation, THA—total hip arthroplasty, TKA—total knee arthroplasty
*Level of evidence is based on the NHMRC evidence hierarchy
Eligibility criteria for outpatient arthroplasty
| Author, year | Inclusion Criteria | Exclusion Criteria |
|---|---|---|
| Gabor, 2020 | Not currently on chronic anticoagulation | Assigned to SDD protocol but were not SDD (discharged before midnight on the day of surgery) |
| No active coronary artery disease or active arrhythmias | Those who completed only one or neither of the preoperative or 12-week postoperative outcome surveys | |
| No active liver disease | ||
| No moderate or severe obstructive sleep apnoea, blood haemoglobin (greater/equal to)12 g/dL, BMI ≤ 40 kg/m2 | ||
| Can ambulate independently | ||
| Patients willing to undergo pre-operative education and had support organised for discharge criteria | ||
| Goyal, 2016 | Primary THA without acute hip fracture or prior hardware that would be removed at the time of surgery | Revision THA or THA |
| Unilateral THA | Preoperative BMI ≥ 40 kg/m2 | |
| Preoperative BMI < 40 kg/m2 | Age ≥ 75 years at the time of surgery | |
| Age < 75 years | Preoperative haemoglobin ≤ 10 g/dL if preoperative haemoglobin data were available | |
| Preoperative Haemoglobin > 10 g/dL | History of cardiopulmonary disease requiring acute inpatient monitoring | |
| Preoperative ambulatory status requires the use of a walker or wheelchair | ||
| Chronic preoperative opioid medication uses or opioid addiction | ||
| Limited or no assistance available at home after discharge from the hospital | ||
| Any other condition or circumstance that would preclude rapid discharge from the hospital | ||
| Gauthier-Kwan, 2018 | Patients undergoing primary TKA for end-stage osteoarthritis of the knee | Not Reported |
| ASA score ≤ 3 with a stable medical profile | ||
| BMI < 45 kg/m2 | ||
| Husted, 2020 | Does not suffer from sleep apnoea and had an ASA score of < 3 | Patients not fulfilling discharge on the DOS |
| Patients who were operated on as 1st or 2nd in the surgical theatre | ||
| Kolisek, 2009 | Discharge within 23 h of the procedure | History of diabetes, myocardial infarction, stroke, congestive heart failure, venous thromboembolism, cardiac arrhythmia, respiratory failure, or chronic pain requiring regular opioid medications |
| Rosinsky, 2020 | Patient decision for outpatient preference | Not reported |
| Hip OA which impaired ADLs and was refractory for minimum 3 months of conservative treatment | ||
| No significant comorbidities | ||
| Zomar, 2021 | 18–75 years | BMI > 40 |
| Undergoing unilateral primary THA via direct approach | Unable to ambulate 10 m without gait aid before surgery | |
| Single surgeon | Undergone ipsilateral TKA | |
| Requiring surgery for the treatment of OA | Comorbidities of the lower extremities affecting gait |
ADL—activities of daily living, ASA—American Society of Anaesthesiologists Physical Status Classification system, BMI—body mass index, DOS—day of surgery, SDD—same day discharge, THA—total hip arthroplasty, TKA—total knee arthroplasty, OA—osteoarthritis
Frequency of functional outcome measures utilised across all studies
| Functional outcome measure | Rosinsky, 2020 | Gabor, 2020 | Gauthier-Kwan, 2018 | Husted, 2020 | Kolisek, 2009 | Goyal, 2016 | Zomar, 2021 | Total |
|---|---|---|---|---|---|---|---|---|
| Harris Hip Score (HHS) | ✓ | ✓ | ✓ | 3 | ||||
| Patient Satisfaction Score | ✓ | ✓ | ✓ | 3 | ||||
| Veterans Rand-12 Item Health Survey (VR-12P) | ✓ | ✓ | 2 | |||||
| Veterans Rand-12 Item Health Survey (VR-12 M) | ✓ | ✓ | 2 | |||||
| Short form: Physical (SF-12P) | ✓ | ✓ | 2 | |||||
| Short form: Mental (SF 12 M) | ✓ | ✓ | 2 | |||||
| Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC, 4-scale) | ✓ | ✓ | 2 | |||||
| Modified Harris Hip Score (mHHS) | ✓ | 1 | ||||||
| Forgotten Joint Score (FJS) | ✓ | 1 | ||||||
| Hip Disability and Osteoarthritis Outcome Score for Joint Replacement (HOOS JR) | ✓ | 1 | ||||||
| Quality of Recovery Scores (QOR-9) | ✓ | 1 | ||||||
| Knee Injury and Osteoarthritis Outcome Score (KOOS, 5-subscale) | ✓ | 1 | ||||||
| Oxford Knee Score (OKS) | ✓ | 1 | ||||||
| Oxford Hip Score (OHS) | ✓ | 1 | ||||||
| Knee Society Score (KSS, 2-subscale) | ✓ | 1 | ||||||
| Knee Range of Motion (KROM) | ✓ | 1 | ||||||
| Visual Analog Scale (VAS) | ✓ | ✓ | ✓ | ✓ | ✓ | 5 | ||
| Numeric Pain Rating Scale (NRS) | ✓ | ✓ | 2 | |||||
| Timed up & go (TUG) | ✓ | 1 | ||||||
| GAIT rite | ✓ | 1 | ||||||
| ✓ outcome measure included |